Skip to main content
Top
Published in: Pediatric Cardiology 3/2019

01-03-2019 | Original Article

A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease

Authors: Lindsey McPhillips, Dipak Kholwadwala, Cristina P. Sison, Dorota Gruber, Kaie Ojamaa

Published in: Pediatric Cardiology | Issue 3/2019

Login to get access

Abstract

Cyanotic heart lesions are a complex subset of congenital heart disease (CHD) in which patients are desaturated until surgical repair or palliation. We hypothesized that a direct relationship would exist between degree of desaturation and presence of systemic inflammation and brain injury in unrepaired patients less than 1 year of age. The pre-operative desaturation with augmented systemic inflammation would predict a more complex post-operative course. Fifty patients with CHD were enrolled in this study and classified as cyanotic (O2 ≤ 90%) or acyanotic (O2 > 90%) based on SpO2. Serum inflammatory mediators measured included interleukins (IL)-6, IL-8, IL-12p70, IL-10, IL-1β, tumor necrosis factor (TNF)-α, interferon (INF)-γ; macrophage inhibitory factor (MIF) and a novel brain biomarker, phosphorylated neurofilament heavy subunit (pNF-H). Twenty-two cyanotic and 28 acyanotic subjects were enrolled with SpO2 of 78 ± 18% and 98 ± 2% (p < 0.001), respectively, and mean age of 72 days (range 2–303) and 102 days (range 1–274), respectively. Cyanotic vs acyanotic subjects had elevated serum IL-6 (6.6 ± 7.6 vs 2.9 ± 2.9 pg/ml, p = 0.019) and pNF-H (222 ± 637 vs 57 ± 121 pg/ml, p = 0.046), and both biomarkers correlated with degree of desaturation (Spearman rank-order correlation ρ = − 0.30, p = 0.037 and ρ = − 0.29 p = 0.049, respectively). Post-operative inotrope scores at 24 h and duration of mechanical ventilation correlated inversely with pre-operative oxygen saturation (ρ = − 0.380, p = 0.014 and ρ = − 0.362, p = 0.020, respectively). The degree of pre-operative desaturation correlated with a more complicated post-operative course supporting the need for advanced peri-operative therapy in this population.
Literature
1.
go back to reference Hoffman JIE, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900CrossRefPubMed Hoffman JIE, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900CrossRefPubMed
2.
go back to reference Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (2013) Moss & Adams’ Heart disease in infants, children, and adolescents: including the fetus and young adult. Lippincott Williams & Wilkins, Philadelphia Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (2013) Moss & Adams’ Heart disease in infants, children, and adolescents: including the fetus and young adult. Lippincott Williams & Wilkins, Philadelphia
4.
go back to reference Hovels-Gurich HH, Schumacher K, Vazquez-Jimenez JF, Qing M, Huffmeier U, Buding B, Messmer BJ, von Bernuth G, Seghaye MC (2002) Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 73(2):601–608CrossRefPubMed Hovels-Gurich HH, Schumacher K, Vazquez-Jimenez JF, Qing M, Huffmeier U, Buding B, Messmer BJ, von Bernuth G, Seghaye MC (2002) Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 73(2):601–608CrossRefPubMed
5.
go back to reference Qing M, Schumacher K, Heise R, Woltje M, Vazquez-Jimenez JF, Richter T, Arranda-Carrero M, Hess J, von Bernuth G, Seghaye MC (2003) Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol 41(12):2266–2274CrossRefPubMed Qing M, Schumacher K, Heise R, Woltje M, Vazquez-Jimenez JF, Richter T, Arranda-Carrero M, Hess J, von Bernuth G, Seghaye MC (2003) Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol 41(12):2266–2274CrossRefPubMed
6.
go back to reference Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D (2006) Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 27:408–413CrossRefPubMed Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D (2006) Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 27:408–413CrossRefPubMed
7.
go back to reference Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C, Ojamaa K (2017) Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 14(1):228–238CrossRefPubMedPubMedCentral Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C, Ojamaa K (2017) Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 14(1):228–238CrossRefPubMedPubMedCentral
8.
go back to reference Allan CK, Newburger JW, McGrath E, Elder J, Psoinos C, Laussen PC, del Nido PJ, Wypij D, McGowan FX Jr (2010) The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg 111(5):1244–1251CrossRefPubMed Allan CK, Newburger JW, McGrath E, Elder J, Psoinos C, Laussen PC, del Nido PJ, Wypij D, McGowan FX Jr (2010) The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg 111(5):1244–1251CrossRefPubMed
9.
go back to reference Mahle WT, Matthews E, Kanter KR, Kogon BE, Hamrick SE, Strickland MJ (2014) Inflammatory response after neonatal cardiac surgery and its relationship to clinical outcomes. Ann Thorac Surg 97(3):950–956CrossRefPubMed Mahle WT, Matthews E, Kanter KR, Kogon BE, Hamrick SE, Strickland MJ (2014) Inflammatory response after neonatal cardiac surgery and its relationship to clinical outcomes. Ann Thorac Surg 97(3):950–956CrossRefPubMed
10.
go back to reference Kozik DJ, Tweddell JS (2006) Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 81(6):S2347–S2354CrossRefPubMed Kozik DJ, Tweddell JS (2006) Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 81(6):S2347–S2354CrossRefPubMed
11.
go back to reference Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT (2012) American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing and Stroke Council, Neurodevelopmental outcomes in children with congenital heart disease; evaluation and management: a scientific statement from the American Heart Association. Circulation 126:1143–1172CrossRefPubMed Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT (2012) American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing and Stroke Council, Neurodevelopmental outcomes in children with congenital heart disease; evaluation and management: a scientific statement from the American Heart Association. Circulation 126:1143–1172CrossRefPubMed
12.
go back to reference Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92(8):2226–2235CrossRefPubMed Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92(8):2226–2235CrossRefPubMed
15.
16.
go back to reference Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Thery 8(Suppl 2):S3CrossRef Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Thery 8(Suppl 2):S3CrossRef
17.
go back to reference Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL (1999) Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol-Lung Cell Mol Physiol 277(5):1057–1065CrossRef Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL (1999) Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol-Lung Cell Mol Physiol 277(5):1057–1065CrossRef
18.
go back to reference Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pederson BK (1997) Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol 76:480–482CrossRef Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pederson BK (1997) Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol 76:480–482CrossRef
19.
go back to reference Matsui H, Ihara Y, Fujio Y, Kunisada K, Akira S, Kishimoto T, Yamauchi-Takihara K (1999) Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes. Cardiovasc Res 42:104–112CrossRefPubMed Matsui H, Ihara Y, Fujio Y, Kunisada K, Akira S, Kishimoto T, Yamauchi-Takihara K (1999) Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes. Cardiovasc Res 42:104–112CrossRefPubMed
20.
go back to reference Vlahopoulos S, Boldlogh I, Casola A, Brasier AR (1999) Nuclear factor-κB–dependent induction of interleukin-8 gene expression by tumor necrosis factor α: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94(6):1878–1889PubMed Vlahopoulos S, Boldlogh I, Casola A, Brasier AR (1999) Nuclear factor-κB–dependent induction of interleukin-8 gene expression by tumor necrosis factor α: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94(6):1878–1889PubMed
21.
go back to reference Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2):311–320CrossRefPubMedPubMedCentral Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2):311–320CrossRefPubMedPubMedCentral
22.
23.
go back to reference Güvener M, Korun O, Demirtürk OS (2015) Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg 30:92–96CrossRefPubMed Güvener M, Korun O, Demirtürk OS (2015) Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg 30:92–96CrossRefPubMed
24.
go back to reference Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Tanaka Y, Toyooka S, Matsuoka N, Morioka K, Ohori Y, Nakamura K, Akai M, Tobimatsu Y, Hamabe Y, Ogata T (2012) Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 50:493–496CrossRefPubMed Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Tanaka Y, Toyooka S, Matsuoka N, Morioka K, Ohori Y, Nakamura K, Akai M, Tobimatsu Y, Hamabe Y, Ogata T (2012) Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 50:493–496CrossRefPubMed
25.
go back to reference Singh A, Kumar V, Ali S, Mahdi AA, Srivastava RN (2017) Phosphorylated neurofilament heavy: a potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illness Injury Sci 7(4):212–217CrossRef Singh A, Kumar V, Ali S, Mahdi AA, Srivastava RN (2017) Phosphorylated neurofilament heavy: a potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illness Injury Sci 7(4):212–217CrossRef
26.
go back to reference Douglas-Escobar M, Yang C, Bennet J, Shuster J, Theriaque D, Leibovici A, Kays D, Zheng T, Rossignol C, Shaw G, Weiss M (2010) A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res 68(6):531–536CrossRefPubMed Douglas-Escobar M, Yang C, Bennet J, Shuster J, Theriaque D, Leibovici A, Kays D, Zheng T, Rossignol C, Shaw G, Weiss M (2010) A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res 68(6):531–536CrossRefPubMed
27.
go back to reference Shedeed SA, Elfaytouri E (2011) Brain maturity and brain injury in newborns with cyanotic congenital heart disease. Pediatr Cardiol 32:47CrossRefPubMed Shedeed SA, Elfaytouri E (2011) Brain maturity and brain injury in newborns with cyanotic congenital heart disease. Pediatr Cardiol 32:47CrossRefPubMed
28.
go back to reference Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G (2013) Cytokine levels in the serum of healthy subjects. Mediat Inflam 2013 (2013) Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G (2013) Cytokine levels in the serum of healthy subjects. Mediat Inflam 2013 (2013)
Metadata
Title
A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease
Authors
Lindsey McPhillips
Dipak Kholwadwala
Cristina P. Sison
Dorota Gruber
Kaie Ojamaa
Publication date
01-03-2019
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 3/2019
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-018-2023-4

Other articles of this Issue 3/2019

Pediatric Cardiology 3/2019 Go to the issue